m6A-dependent microRNA binding to chromatin-associated RNA for transcriptional activation

This study reveals that microRNAs, canonically known as post-transcriptional repressors, can drive transcriptional activation by binding to m6A-modified chromatin-associated RNAs to recruit AGO proteins and subsequently recruit chromatin remodelers and DNA demethylases, thereby establishing a permissive chromatin environment.

The Gist

Imagine your DNA is a massive, ancient library. Inside this library, the books (genes) contain the instructions for building and running your body. Usually, the library is very organized: some books are locked in a heavy, dark vault (tightly packed chromatin) where no one can read them, while others are sitting out on open shelves (open chromatin) ready to be read.

For decades, scientists believed that microRNAs were like the library's strict "security guards." Their only job was to find specific books, rip out the pages, or lock them away to stop them from being read. They were seen purely as the "brakes" of the system, turning things off.

But this new research from the University of Chicago reveals that these security guards have a secret second job: they can also be the "open sesame" keys that unlock the vaults and turn things on.

Here is how this new mechanism works, broken down into a simple story:

1. The Special Keys (AAGUGC-seed microRNAs)

Not all microRNAs are the same. The researchers found a specific family of these molecules (the "AAGUGC-seed" family) that act like master keys. Instead of just breaking books, these keys travel into the nucleus (the library's control room) and look for specific spots on the library's shelves.

2. The Sticky Note System (m6A)

The library shelves aren't just plain wood; some spots have special glowing sticky notes on them. In science, these are called m6A marks. These sticky notes act as a "Here I am!" signal.

3. The Double-Lock Mechanism

Here is the magic trick:

• The Anchor: A protein called FXR1/2 sees the glowing sticky note (m6A) and grabs onto it. It acts like a heavy anchor, holding the spot steady.
• The Guide: The microRNA (the master key) then guides a protein called AGO to the exact same spot, matching up like a puzzle piece.

Because the anchor (FXR) and the guide (microRNA) are both holding on, the whole team (the microRNA + AGO complex) gets super-stable. They don't slip off; they lock firmly onto that specific spot on the DNA.

4. Calling the Construction Crew

Once this team is locked in place, they start ringing the phone to call in the construction crew:

• The Demolition Crew (SMARCA4/BRG1): This crew comes in and physically pushes the heavy, locked vault doors open. They make the DNA "accessible," turning the dark vault into an open shelf.
• The Eraser Crew (TET1): This crew comes in and wipes away old "Do Not Read" signs (DNA methylation) that were blocking the book.

5. The Result: A Library Explosion

With the vaults open and the "Do Not Read" signs gone, the library goes wild. Hundreds of books that were previously silent suddenly start being read. The cell starts producing proteins it didn't make before.

Why Does This Matter?

• It changes the rules: We thought microRNAs only turned genes off. Now we know they can turn them on too, but only when they find that specific "sticky note" (m6A) on the DNA.
• It explains disease: The researchers found this happening in Leukemia (a blood cancer) and Colon Cancer. In these diseases, the "master keys" are overactive, forcing the library to keep reading dangerous books that help the cancer grow.
• It's a universal tool: This isn't just happening in one type of cell. It happens in stem cells (the body's building blocks) and other cancers too.

The Big Picture Analogy

Think of your genes as a dimmer switch for the lights in your house.

• Old View: MicroRNAs were thought to be the person who just unplugs the lamp (turning it off).
• New View: This paper shows that some microRNAs are actually the person who finds the hidden switch behind a painting, flips the dimmer up, and floods the room with light. They need a specific "glowing sticker" (m6A) to know exactly which switch to flip, and they need a helper (FXR) to hold the ladder steady while they do it.

This discovery opens up a whole new way to think about how our genes are controlled and offers new ideas for how we might fix broken switches in diseases like cancer.

Technical Summary

1. Problem Statement

For decades, microRNAs (miRNAs) have been canonically defined as post-transcriptional repressors that function in the cytoplasm to degrade mRNA or inhibit translation. While nuclear functions of miRNAs and Argonaute (AGO) proteins have been suggested, and "RNA-induced gene activation" (RNAa) has been observed with synthetic siRNAs, the mechanisms governing endogenous miRNA-mediated transcriptional activation remain poorly understood. Key gaps include:

• The lack of systematic mapping of endogenous miRNA binding sites on chromatin-associated RNAs (caRNAs).
• The unclear molecular pathways linking miRNA binding to chromatin remodeling and transcriptional activation.
• The role of RNA modifications, specifically N6-methyladenosine (m6A), in recruiting miRNA-AGO complexes to specific genomic loci.

2. Methodology

The authors employed a multidisciplinary approach combining genomics, epigenomics, biochemistry, and cell biology across multiple cell types (K562 leukemia, HCT116 colon cancer, and mouse embryonic stem cells).

• Genomic & Epigenomic Profiling:
  • ATAC-seq & DNase I-TUNEL: To measure global chromatin accessibility.
  • CUT&Tag: To map histone modifications (H3K4me3, H3K27ac, H3K9me3, H3K27me3) and protein binding (AGO1/2, SMARCA4/BRG1, FXR1/2, TET1).
  • Nascent RNA Sequencing: Using 5-ethynyl uridine (5-EU) labeling and 4-thiouridine (4sU) incorporation (quantified by LC-MS/MS) to measure transcription rates.
  • m6A Mapping: Integration of m6A-seq data to correlate modification sites with protein binding.
• Binding Site Mapping:
  • Developed a customized chimeric eCLIP (CrossLinking and ImmunoPrecipitation) approach to map specific binding sites of AAGUGC-seed miRNAs on chromatin-associated RNAs, overcoming low ligation efficiency challenges in nuclear fractions.
  • Used Chromatin RIP-qPCR with biotinylated miRNA mimics to validate direct binding to specific transcripts (e.g., YTHDF2).
• Functional Assays:
  • CRISPR/Cas9 & siRNA/shRNA: To knock out or knock down specific miRNAs, AGO proteins, m6A readers (FXR1/2), and chromatin remodelers (SMARCA4/BRG1).
  • RNA Decay Assays: Actinomycin D treatment to distinguish transcriptional activation from post-transcriptional stability changes.
  • Cell Phenotyping: Proliferation and migration assays in cancer models.
• Bioinformatics: Correlation analysis of TCGA-AML and pan-cancer datasets to link expression levels of the identified pathway components.

3. Key Contributions & Results

A. Discovery of Transcriptional Activation by AAGUGC-Seed miRNAs

• The study identified a specific family of miRNAs with the AAGUGC seed sequence (including miR-17, miR-20a, miR-20b, miR-93, miR-106a, miR-106b) that are highly correlated with YTHDF2 expression in Acute Myeloid Leukemia (AML).
• Unlike canonical repression, overexpression of these miRNAs increased YTHDF2 transcript levels and nascent RNA synthesis, while knockdown reduced them.
• Mechanistically, this activation occurs at the transcriptional level (increased promoter accessibility and nascent synthesis) rather than via mRNA stabilization.

B. The m6A-Dependent Dual-Anchoring Mechanism

The authors elucidated a novel "dual-anchoring" model where miRNAs and m6A modifications cooperate to recruit machinery to chromatin:

1. m6A Recognition: m6A-binding proteins FXR1 and FXR2 recognize m6A marks on chromatin-associated RNAs (caRNAs).
2. Protein Recruitment: FXR1/2 directly interact with and recruit AGO1/2 to these m6A-marked loci.
3. Sequence Specificity: Once anchored by FXR1/2-m6A, AGO1/2 are guided by the AAGUGC-seed miRNAs to bind specific complementary sequences on the caRNAs.
4. Stabilization: This dual interaction (m6A-FXR-AGO and miRNA-AGO-sequence) stabilizes the complex at specific genomic loci.

C. Recruitment of Epigenetic Effectors

The stabilized AGO-miRNA/FXR-m6A complex recruits two distinct effectors to drive transcription:

• SMARCA4 (BRG1): Recruited via AGO1/2. As an ATP-dependent chromatin remodeler, BRG1 promotes chromatin opening (increased accessibility) and deposition of active histone marks (H3K4me3, H3K27ac).
• TET1: Recruited via FXR1/2. TET1 facilitates DNA demethylation, further enhancing chromatin accessibility and transcriptional permissiveness.

D. Broad Applicability

• Cell Type Generality: This mechanism was validated in colon cancer (HCT116) and mouse embryonic stem cells (mESCs), where AAGUGC-seed miRNAs (e.g., miR-290-295 cluster) are dominant and drive global transcriptional activation.
• Beyond AAGUGC: The study suggests that other miRNAs and siRNAs with different seed sequences can also induce transcriptional activation, implying this is a broader property of small RNAs binding to m6A-marked caRNAs, rather than a unique feature of the AAGUGC family.

4. Significance

• Paradigm Shift: This work fundamentally challenges the dogma that miRNAs are exclusively post-transcriptional repressors, establishing a robust mechanism for endogenous miRNA-mediated transcriptional activation.
• Mechanistic Insight: It resolves the long-standing mystery of how small RNAs target chromatin, revealing that m6A modifications on caRNAs serve as a critical recruitment platform for AGO complexes.
• Therapeutic Implications: The discovery of the miRNA-m6A-AGO-SMARCA4/TET1 axis offers new targets for cancer therapy. Since AAGUGC-seed miRNAs are upregulated in AML relapse and drive metastasis in colon cancer, disrupting this axis could suppress oncogene expression.
• Tool Development: The findings suggest that designed small RNAs could be engineered to target specific m6A-marked loci to upregulate therapeutic genes (transcriptional upregulation), expanding the utility of RNA-based therapeutics beyond silencing.

Conclusion

Zhong et al. demonstrate that AAGUGC-seed microRNAs, in conjunction with m6A-binding proteins FXR1/2, form a stable complex on chromatin-associated RNAs. This complex recruits the chromatin remodeler SMARCA4 (BRG1) and the DNA demethylase TET1, creating a permissive chromatin environment that drives robust transcriptional activation across hundreds of genes. This m6A-dependent regulatory logic represents a conserved mechanism for gene activation in diverse cellular contexts, including cancer and development.